The largest database of trusted experimental protocols

2 protocols using 4 hydroxymethyl phenylacetic acid

1

Purification and Characterization of Xanthine Oxidase Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quercetin, isorhamnetin, tamarixetin, and 3-coumaric acid were purchased from Extrasynthese. Quercetin-3′-sulfate, Quercetin-3-glucuronide, and isorhamnetin-3-glucuronide were synthetized as described [45 (link)]. xanthine oxidase (from bovine milk), allopurinol, 6-mercaptopurine, hypoxanthine, xanthine, uric acid, oxipurinol, 3-phenylpropionic acid, 3-(4-hydroxyphenyl)propionic acid, 3-(2,4-dihydroxyphenyl)propionic acid, 2-hydroxyphenylacetic acid, 4-hydroxyphenylacetic acid, 3,4-dihydroxyphenylacetic acid, 3-hydroxy-4-methoxyphenylacetic acid, 4-(hydroxymethyl)phenylacetic acid, benzoic acid, 4-hydroxybenzoic acid, 2,4-dihydroxybenzoic acid, 3,4-dihydroxybenzoic acid, hippuric acid, 2,4-dihydroxyacetophenon, 4-methylcatechol, resorcinol, pyrogallol, phloroglucinol, 4-methoxysalicylic acid, and homovanillic acid were obtained from Sigma-Aldrich (St. Louis, MO, US). 3-(3-hydroxyphenyl)propionic acid and 3-(3,4-dihydroxyphenyl)propionic acid were purchased from Toronto Research Chemicals. 6-thiouric acid was obtained from Carbosynth, 6-thioxanthine was purchased from 5A Pharmatech. uric acid was dissolved in 0.01 M sodium hydroxide (2 mM), while Q and its metabolites, APU, 6-MP, 6-TX, 6-TU, and xanthine were dissolved in dimethyl sulfoxide (each 2 mM) and stored at –20 °C.
+ Open protocol
+ Expand
2

Structural Insights from Inhibitor Soaks

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two additional complexes were obtained from soaks. One including Tris and DMSO (PDB code 6MKM) was obtained from a soak that also included a reported arylstibonic acid inhibitor, compound 13755, from the NCI Diversity Set. In this case, the crystals were grown as described above and then soaked in 100 mM Tris, pH 7.5, 200 mM NaCl, 1 mM 13755 (dissolved in DMSO resulting in a final concentration of 4% DMSO), and 20% PEG 3350. Crystals were cryocooled in 100 mM Tris-Cl, pH 7.5, 200 mM NaCl, 20% PEG 3350, 1 mM 13755, 4% DMSO, and 20% ethylene glycol. The second complex included Mg2+ and DMSO (PDB code 6MKK), obtained from a soak including 20 mM 4-hydroxymethylphenylacetic acid (Sigma-Aldrich) along with 1 mM MgCl2. Crystals were cryocooled in 100 mM MES, pH 6.0, 200 mM NaCl, 22% PEG4000, 20–22% ethylene glycol, 20 mM 4-(hydroxymethyl)-phenylacetic acid, and 4% DMSO. In each of these complexes, the inhibitor was not evident in the difference electron density map but DMSO was bound to the abasic sugar site with either Mg2+ or Tris in the metal binding site.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!